GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
GBR 830 is a humanized mAb against OX40, a costimulatory receptor on activated T cells. OX40 inhibition might have a therapeutic role in T cell–mediated diseases, including atopic dermatitis (AD). This exploratory phase 2a study investigated the safety, efficacy, and tissue effects of GBR 830 in pat...
Saved in:
| Published in: | Journal of allergy and clinical immunology Vol. 144; no. 2; pp. 482 - 493.e7 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Inc
01.08.2019
Elsevier Limited |
| Subjects: | |
| ISSN: | 0091-6749, 1097-6825, 1097-6825 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!